Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Post by longondmxon Jan 05, 2010 8:12am
267 Views
Post# 16638521

Can anyone...

Can anyone...tell what brokerage house Maxam may be using to purchase shares in the market?  Can you tell what house they used to acquire Bancorp shares back in December (when they were buying at $1.30).  The site I go to doesn't give the history of trades that far back.

Reason I ask is that there has been some buying from Haywood that I suspect may be Maxam in the $1.32-1.33 range the last few trading days.  https://www.quotemedia.com/results.php?qm_page=16662&qm_symbol=bkp:ca

If Maxam purchased shares in the $1.30 price a few weeks ago, I suspect they are still acquiring in the open market even at a higher price with the anticipation of raising their bid soon (or at the very least, in anticipation of other competing bids).

I really doubt they will abandon their attempt to buy out Bancorp since that would likely mean a decrease in the price of the shares they just bought/own.

Bullboard Posts